Clostridium innocuum bacteremia in a patient with acquired immunodeficiency syndrome

American Journal of the Medical Sciences

Volumn 337, Issue 6, 2009, Pages 480-482

  Crum Cianflone, Nancy ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Clostridium difficile infection; Clostridium innocuum bacteremia; HIV; Vancomycin

Indexed keywords

CREATININE; DAPTOMYCIN; IMIPENEM; LINEZOLID; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; AIDS PATIENT; ANAMNESIS; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTEREMIA; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM INNOCUUM; CREATININE BLOOD LEVEL; DIARRHEA; FECES ANALYSIS; FECES CULTURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LYMPHADENOPATHY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED INFECTION; MYCOBACTERIUM AVIUM; RISK FACTOR; WOUND HEALING; ADOLESCENT; AGED; AIDS RELATED COMPLEX; CLOSTRIDIUM INFECTION; FEMALE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 67650239868     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31819f1e95     Document Type: Article

References (13)

1. Bodey GP, Rodriguez S, Fainstein V, et al. Clostridial bacteremia in cancer patients. A 12-year experience. Cancer 1991;67:1928-1942
2. Gorbach SL, Thadepalli H. Isolation of Clostridium in human infections: evaluation of 114 cases. J Infect Dis 1975;131:S81-5.
3. Saxena R, Adolph M, Ziegler JR, et al. Pylephlebitis: a case report and review of outcome in the antibiotic era. Am J Gastroenterol 1996;91:1251-1253 (Pubitemid 26175494)
4. Castiglioni B, Gautam A, Citron DM, et al. Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient. Transpl Infect Dis 2003;5:199-202.
5. Smith LD, King E. Clostridium innocuum, sp. n., a sporeforming anaerobe isolated from human infections. J Bacteriol 1962;83:938-939
6. Ackermann G, Tang YJ, Jang SS, et al. Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea. Diagn Microbiol Infect Dis 2001;40:103-106
7. Cutrona AF, Watanakunakorn C, Schaub CR, et al. Clostridium innocuum endocarditis. Clin Infect Dis 1995;21:1306-1307
8. Gottesdiener KM, Weinstein L. Clostridial bacteremia: patterns of infection. Infect Dis Clin Pract 1994;3:182-192
9. Alexander CJ, Citron DM, Brazier JS, et al. Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol 1995;33:3209-3215
10. Goldstein EJ, Citron DM, Merriam CV, et al. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. Antimicrob Agents Chemother 2004;48:2149-2152
11. Mory F, Lozniewski A, David V, et al. Low-level vancomycin resistance in Clostridium innocuum. J Clin Microbiol 1998;36:1767-1768
12. David V, Bozdogan B, Mainardi JL, et al. Mechanism of intrinsic resistance to vancomycin in Clostridium innocuum NCIB 10674. J Bacteriol 2004;186:3415-3422
13. Grasberger RC, Pietrafitta JJ, Deckers PJ. Non-spore-forming clostridial bacteremia. J Surg Oncol 1984;25:188-191